ArticlePloS one2024

Blockade of SIRPα-CD47 axis by anti-SIRPα antibody enhances anti-tumor activity of DXd antibody-drug conjugates.

Mayumi Sue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.